Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$4.12B |
| 2 |
Gilead Sciences
GILD
|
+$379M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$286M |
| 4 |
Amazon
AMZN
|
+$271M |
| 5 |
Meta Platforms (Facebook)
META
|
+$266M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$762M |
| 2 |
SPDR Gold Trust
GLD
|
+$410M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$400M |
| 4 |
QIHU
QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS
QIHU
|
+$227M |
| 5 |
Synchrony
SYF
|
+$195M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 2.31% |
| 2 | Technology | 1.26% |
| 3 | Financials | 1.12% |
| 4 | Healthcare | 1.04% |
| 5 | Consumer Discretionary | 0.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1426
PUT
Nordic American Tanker
NAT
$1.46B
| $11.2M | 0.01% |
1,114,747
+288,993
| +35% | +$3.36M |
|
1427
ResMed
RMD
$34.1B
| $11.2M | 0.01% |
172,406
+17,557
| +11% | +$1.17M |
|
1428
Ares Capital
ARCC
$14.3B
| $11.2M | 0.01% |
720,158
-513,780
| -42% | -$7.88M |
|
|
RICE
1429
PUT
DELISTED
Rice Energy Inc.
RICE
| $11.2M | 0.01% |
427,500
+359,300
| +527% | +$8.92M |
|
1430
Baxter International
BAX
$13.6B
| $11.1M | 0.01% |
233,537
-672,995
| -74% | -$31.7M |
|
1431
CALL
Hain Celestial
HAIN
$78.9M
| $11.1M | 0.01% |
312,400
+35,400
| +13% | +$1.55M |
|
1432
CALL
Neurocrine Biosciences
NBIX
$15.6B
| $11.1M | 0.01% |
219,500
-202,800
| -48% | -$10.1M |
|
1433
PUT
Direxion Daily Gold Miners Index Bear 2X ETF
DUST
$64.4M
| $11.1M | 0.01% |
132
+94
| +247% | +$7.25M |
|
1434
CALL
First Majestic Silver
AG
$10.5B
| $11.1M | 0.01% |
1,074,400
-98,300
| -8% | -$1.44M |
|
1435
CALL
Healthpeak Properties
DOC
$14.9B
| $11.1M | 0.01% |
319,847
+189,844
| +146% | +$6.64M |
|
|
ASRT
1436
PUT
DELISTED
Assertio
ASRT
| $11M | 0.01% |
7,367
+4,689
| +175% | +$5.89M |
|
1437
CALL
WisdomTree Europe Hedged Equity Fund
HEDJ
$1.84B
| $11M | 0.01% |
411,000
-4,972,800
| -92% | -$131M |
|
|
MLNX
1438
PUT
DELISTED
Mellanox Technologies, Ltd.
MLNX
| $11M | 0.01% |
255,000
+146,900
| +136% | +$6.5M |
|
1439
CALL
Aptiv
APTV
$9.68B
| $11M | 0.01% |
154,500
+6,400
| +4% | +$432K |
|
1440
CALL
W.W. Grainger
GWW
$61.3B
| $11M | 0.01% |
49,000
-39,700
| -45% | -$8.92M |
|
|
WR
1441
PUT
DELISTED
Westar Energy Inc
WR
| $11M | 0.01% |
193,900
+30,900
| +19% | +$1.71M |
|
1442
Invesco CurrencyShares Swiss Franc Trust
FXF
$385M
| $11M | 0.01% |
111,405
+78,088
| +234% | +$7.67M |
|
1443
PUT
Leidos
LDOS
$16.9B
| $11M | 0.01% |
253,500
+187,000
| +281% | +$8.49M |
|
|
K
1444
PUT
DELISTED
Kellanova
K
| $11M | 0.01% |
150,804
+31,843
| +27% | +$2.44M |
|
1445
CALL
Chord Energy
CHRD
$7.7B
| $11M | 0.01% |
954,900
+183,400
| +24% | +$1.68M |
|
1446
Range Resources
RRC
$9.58B
| $10.9M | 0.01% |
282,533
-305,803
| -52% | -$12.4M |
|
1447
Chevron
CVX
$392B
| $10.9M | 0.01% |
106,226
-7,842
| -7% | -$801K |
|
1448
PUT
Willis Towers Watson
WTW
$32.2B
| $10.9M | 0.01% |
82,200
+77,400
| +1,613% | +$9.64M |
|
|
ULTI
1449
PUT
DELISTED
Ultimate Software Group Inc
ULTI
| $10.9M | 0.01% |
53,400
+16,900
| +46% | +$3.57M |
|
|
SBNY
1450
PUT
DELISTED
Signature Bank
SBNY
| $10.9M | 0.01% |
92,000
+42,400
| +85% | +$5.1M |
|
Similar funds
Jeff Yass's Q3 2016 Portfolio in Review
As of Q3 2016, Jeff Yass held 9,816 positions worth $207B, up 11% from $187B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Jeff Yass deployed $7.99B of net new capital in Q3 2016, opening 1,347 new positions and adding to 3,278 existing holdings. Its largest new stake was Bristol-Myers Squibb: 4,459,411 shares worth $240M.
By sector, the portfolio is most concentrated in Consumer Staples at 2.3% of assets, up from 0.28% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Apple, an estimated $762M trimmed.
- Jeff Yass's largest Q3 2016 buy was Bristol-Myers Squibb: 4,459,411 shares worth $240M.
- Jeff Yass added most to Procter & Gamble in Q3 2016, an estimated $4.12B increase.
- Jeff Yass's biggest Q3 2016 reduction was Apple, cutting an estimated $762M.
- Jeff Yass fully exited QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS in Q3 2016, selling an estimated $227M.
- Jeff Yass's ten largest holdings make up 27% of its $207B portfolio in Q3 2016.
- Jeff Yass opened 1,347 new positions and closed 1,488 in Q3 2016.
- Jeff Yass's portfolio value rose 11% quarter-over-quarter to $207B.
Based on Susquehanna International Group's 13F filing for Q3 2016, filed 14 Nov 2016.